RxDoctor Payments Data

Nikki Rose Angeles, APRN

Nurse Practitioner · Live Oak, TXNPI 1073214961

Payments from drug & device makers

$1,455in general payments, 2019–2025

Across 70 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$272
  • Johnson & Johnson$196
  • Lexicon Pharmaceuticals, Inc.$127
  • Pfizer$118
  • Atricure, Inc.$98
  • E.r. Squibb & Sons, L.L.C.$96
  • plus $547 from 15 others

What the payments were for

  • Food & beverage$1,455100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,455 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Medicare billing

Part B allowed, 2024
$1,399
Medicare patients
20
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban235$299,038
EntrestoSacubitril/Valsartan84$108,826
XareltoRivaroxaban64$60,729
FarxigaDapagliflozin Propanediol39$41,978
MultaqDronedarone Hcl11$23,907
BrilintaTicagrelor26$17,784
Repatha SyringeEvolocumab13$12,971
Metoprolol Succinate439$5,053
Atorvastatin Calcium338$2,861
Rosuvastatin Calcium174$2,230
Nifedipine ErNifedipine75$2,035
Losartan Potassium197$1,777
Bumetanide35$1,429
ClopidogrelClopidogrel Bisulfate150$1,357
Carvedilol195$1,321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$118$299,038235 claims
NovartisEntresto$272$108,82684 claims
Johnson & JohnsonXarelto$196$60,72964 claims
AstraZenecaFarxiga, Brilinta$15$59,76265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Live Oak

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →